Trial Profile
A Phase I trial of AR1001 for Vascular dementia.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Oct 2016
Price :
$35
*
At a glance
- Drugs Mirodenafil (Primary)
- Indications Vascular dementia
- Focus Adverse reactions
- 21 Oct 2016 New trial record